Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse

Molecular Psychiatry

Volumn 3, Issue 1, 1998, Pages 50-60

  Gade, R ^a   Muhleman, D ^a   Blake, H ^a   MacMurray, J ^b   Johnson, P ^c   Verde, R ^c   Saucier, G ^d   Comings, D E ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

^c Jerry L Pettis VA Hospital   (United States)

^d CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Alcoholism; Attention deficit hyperactivity disorder; Minisatellites; Polygenic inheritance

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING);

ALCOHOLISM; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DRUG ABUSE; ENZYME ACTIVITY; FEMALE; GENE CONTROL; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GILLES DE LA TOURETTE SYNDROME; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIFACTORIAL INHERITANCE; PHENOTYPE; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT; X CHROMOSOME LINKAGE;

EID: 0031963425     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000326     Document Type: Article

References (65)

1. Ozelius L, Hus Y-PP, Bruns G, Powell JF, Chen S, Weyler W, Utterback M et al. Human monamine oxidase gene (MAOA): chromosome position (Xp21-p11) and DNA polymorphism. Genomics 1988; 3: 53-58.
2. Kochersperger LM, Parker EL, Sicillano M, Darlington GJ, Denney RM. Assignment of genes for human monamine oxidase A and B to the X chromosome. J Neurosci Res 1986; 16: 601-619.
3. Lan CL, Heinzmann C, Gal A, Klisak I, Orth U, Lai E, Grimsley J, Sparkes RS, Mohandas T, Shih JC. Human monamine oxidase A and B genes map to Xp11.23 and are deleted in a patient with Norrie disease. Genomics 1989; 4: 552-559.
4. Grimsby J, Chen K, Wang LJ, Lan N, Shih JC. Human monamine oxidase A and B genes exhibit identical exon-intron organization. Proc Natl Acad Sci USA 1991; 88: 3637-3641.
5. Weyler W, Hsu Y-PP, Breakefield XO. Biochemistry and genetics of monamine oxidase. J Pharmacol Ther 1990; 47: 391-417.
6. Wiberg A, Gottfries CG, Oreland L. Low platelet monoamine oxidase activity in human alcoholics. Med Biol 1977; 55: 181-186.
7. Gottfries CG, Oreland L, Wiberg A, Winblad B. Lowered monoamine oxidase activity in brains from alcoholic suicides. J Neurochem 1975; 25: 667-673.
8. Devor EJ, Cloninger CR, Hoffman PL, Tabakoff B. Association of monoamine oxidase (MAO) activity with alcoholism and alcoholic subtypes. Am J Med Genet 1994; 48: 209-213.
9. Vonknorring AL, Hallmann J, Vonknorring L, Oreland L. Platelet monoamine oxidase activity in type-1 and type-2 alcoholism. Alcohol Alcohol 1991; 26: 409-416.
10. Wyatt RJ, Potkin SG, Murphy DL. Platelet monamine oxidase activity in schizophrenia: a review of the data. Am J Psychiatry 1979; 136: 377-385.
11. Sherif F, Marcusson J, Oreland L. Brain gamma-aminobutyrate transaminase and monoamine oxidase activities in suicide victims. Eur Arch Psychiatry Clin Neurosci 1991; 241: 139-144.
12. Pandey GN, Sharma RP, Janicak PG, Davis JM. Monamine oxidase and cortisol response in depression and schizophrenia. Psychiatry Res 1992; 44: 1-8.
13. Pandey GN, Dorus E, Shaughnessy R, Gaviria M, Val E, Davis JM. Reduced platelet MAO activity and vulnerability to psychiatric disorders. Psychiatry Res 1980; 2: 315-321.
14. Buchsbaum MS, Coursey RD, Murphy DL. The biochemical high-risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity. Science 1976; 194: 339-341.
15. Buchsbaum MS, Haier RJ, Murphy DL. Suicide attempts, platelet monamine oxidase and the average evoked response. Acta Psychiatr Scand 1977; 56: 69-79.
16. Meltzer HY, Arora RC. Platelet markers of suicidality. Ann N Y Acad Sci 1986; 487: 271-280.
17. Skekim WO, Davis LG, Bylund DB, Brunngraber E, Fikes L, Lanham J. Platelet MAO in children with attention deficit disorder and hyperactivity: a pilot study. Am J Psychiatry 1982; 139: 936-938.
18. Schooler C, Zahn TP, Murphy DL, Buchsbaum MS. Psychological correlates of monoamine oxidase activity in normals. J Nerv Ment Dis 1978; 166: 177-186.
19. Shekim WO, Bylund DB, Frankel F, Alexson J, Jones SB, Blue LO, Kirby J, Corchoran C. Platelet MAO activity and personality variations in normals. Psychiatry Res 1989; 27: 81-88.
20. Vonknorring L, Oreland L, Winblad B. Personality traits treated to monoamine oxidase activity in platelets. Psychiatry Res 1984; 12: 11-26.
21. Mann JJ, Stanley M. Postmortem monoamine oxidase enzyme kinetics in the frontal cortex of suicide victims and controls. Acta Psychiatr Scand 1984; 69: 135-139.
22. Propping P, Rey ER, Friedl W, Beckmann H. Platelet monoamine oxidase in healthy subjects: the 'biochemical high-risk paradigm' revisited. Arch Psychiatr Nervenkr 1981; 230: 209-219.
23. Tabakoff B, Hoffman PL, Lee JM, Saito T, Willard B, Leon-Jones FD. Differences in platelet enzyme activity between alcoholics and nonalcoholics. New Eng J Med 1988; 318: 134-139.
24. Fowler CJ, Tipton KF, MacKay AVP, Youdin BH. Human platelet monoamine oxidase - a useful enzyme in the study of psychiatric disorders. Neuroscience 1982; 7: 1577-1594.
25. Hotamisligil GS, Breakefield XO. Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 1994; 49: 383-392.
26. Lin LCC, Powell JF, Murray R, Gill M. Monoamine oxidase A gene and bipolar affective disorder. Am J Hum Genet 1994; 54: 1122-1124.
27. Craddock N, Daniels J, Roberts E, Rees M, McGuffin P, Owen MJ. No evidence for allelic association between bipolar disorder and monoamine oxidase A gene polymorphisms. Am J Med Gen (Neuropsych Genet) 1995; 60: 322-324.
28. Nöthen MM, Eggerman K, Albus M, Borrmann M, Rietschel M, Körner J, Maier W, Minges J, Lichtermann D, Franzek E, Weigelt B, Knapp M, Propping P. Association analysis of the monamine oxidase A gene in bipolar affective disorder by using family-based internal controls. Am J Hum Genet 1995; 57: 975-977.
29. Brunner HG, Nelen MR, van Zandvoort P, Abeling NGGM, van Gennip AH, Wolters EC, Kuiper MA, Ropers HH, van Oost BA. X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization and evidence for disturbed monoamine metabolism. Am J Hum Genet 1993; 52: 1032-1039.
30. Brunner HG, Helen M, Breakefield XO, Ropers HH, van Oost BA. Abnormal behavior linked to a point mutation in the structural gene for monamine oxidase A. Psychiat Genet 1993; 3: 122.
31. Vanyukov MM, Moss HB, Plail JA, Blackson T, Mezzich AC, Tarter REI. Antisocial symptoms in preadolescent boys and in their parents: associations with cortisol. Psychiatr Res 1993; 46: 9-17.
32. Black GCM, Chenz Y, Craig IW, Powell JF. Dinucleotide repeat polymorphism at the MAOA locus. Nucleic Acids Res 1991; 19: 689.
33. Comings DE. The role of genetic factors in conduct disorder based on studies of Tourette syndrome and ADHD probands and their relatives. J Dev Behav Pediatr 1995; 16: 142-157.
34. Comings DE. The role of genetic factors in human sexual behavior based on studies of Tourette syndrome and ADHD probands and their relatives. Am J Med Gen (Neuropsych Genet) 1994; 54: 227-241.
35. Comings DE. Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. I. Drug abuse. Drug and Alcohol Dependence 1994; 35: 1-16.
36. Comings DE. Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. II. Alcohol abuse. Drug and Alcohol Dependence 1994; 35: 17-24.
37. Comings DE. Tourette syndrome: a hereditary neuropsychiatric spectrum disorder. Ann Clin Psychiatry 1995; 6: 235-247.
38. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 1991; 148: 564-577.
39. Hinds HL, Hendricks RW, Craig IW, Chen ZY. Characterization of a highly polymorphic region near the first exon of the human MAOA gene containing a GT dinucleotide and a novel VNTR motif. Genomics 1992; 13: 896-897.
40. Comings DE, Wu H, Chiu C, Ring RH, Dietz G, Muhleman D. Polygenic inheritance of Tourette syndrome, stuttering, ADHD, conduct and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes - DRD2, DβH and DAT1. Am J Med Gen (Neuropsych Genet) 1996; 67: 264-288.
41. Comings DE, MacMurray JP, Gade R, Muhleman D, Peters WR. Genetic variants of the human obesity gene: association with psychiatric symptoms and body mass index in young women, and interaction with the dopamine D2 receptor gene. Mol Psychiatry 1996; 1: 325-335.
42. Johnson JP, Muhleman D, MacMurray J, Gade R, Verde R, Ask M, Kelley J, Comings DE. Association between the cannabinoid receptor gene (CNR1), and the P300 wave of event-related potentials, and drug dependence. Mol Psychiatry 1997; 2: 169-171.
43. Comings DE, Muhleman D, Gade R, Johnson P, Verde R, Saucier G, MacMurray J. Cannabinoid receptor gene (CNR1): association with IV drug use. Mol Psychiatry 1997; 2: 101-168.
44. Comings D, Gade R, Muhleman D, MacMurray J. Role of the HTR1A serotonin receptor gene in Tourelle syndrome and conduct disorder. Psychiat Genet 1996; 6: 166.
45. A-b3 and dopamine DRD4 gene markers. Psychiat Genet 1996; 6: 161.
46. Gade R, Blake H, MacMurray J, Muhleman D, Johnson J, Verde R, Comings D. Relationship of the GABRB3 gene to adult ADHD and personality traits in Caucasian and African-American samples. Psychiat Genet 1996; 6: 104-165.
47. Comings DE. Polygenic inheritance and micro/minisatellites. Mol Psychiatry 1998; 3: 21-31.
48. Schroth GP, Chou P-J, Ho PS. Mapping Z-DNA in the human genome. J Biol Chem 1992; 267: 11846-11855.
49. Rich A, Nordheim A, Wang AJ. The chemistry and biology of left-handed Z-DNA. Annu Rev Biochem 1984; 53: 791-856.
50. Comings DE. Polygenic inheritance and minisatellites. Psychiat Genet 1996; 6: 157-158.
51. Comings DE. Polygenic inheritance of psychiatric disorders. In: Blum K, Noble EP, Sparks RS, Sheridan PJ (eds). Handbook of Psychiatric Genetics. CRC Press: Boca Raton, FL, 1996, pp 235-260.
52. Comings DE. Tourette Syndrome and Human Behavior. Hope Press: Duarte, CA, 1990, pp 1-828.
53. Comings DE, Gade R, Wu S, Chiu C, Dietz G, Muhleman D, Saucier G, Ferry L, Burchete R, Johnson P, Verde R, MacMurray JP. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol Psychiatry 1997; 2: 44-56.
54. Robins LN, Helzer J, Croughan J, Ratclif KS. National Institute of Health diagnostic interview schedule. Arch Gen Psychiatry 1981; 38: 381-389.
55. Diagnostic and Statistical Manual of Mental Disorders. 3rd edn, revised. American Psychiatric Association: Washington, DC, 1987.
56. Comings DE. Genetic factors in depression based on studies of Tourette syndrome and Attention Deficit Hyperactivity Disorder probands and relatives. Am J Med Gen (Neuropsych Genet) 1995; 60: 111-121.
57. Gadow KD, Sprafkin J. Child Symptom Inventories Manual. Checkmate Plus Ltd: Stony Brook, NY, 1994, pp 1-115.
58. Grayson P, Carlson G. The utility of a DSM-III-R based checklist in screening child psychiatric patients. J Am Acad Child Adolesc Psychiatry 1991; 30: 669-673.
59. Davis LL, Hurt RD, Morse RM, O'Brien PC. Discriminant analysis of the self-administered alcoholism screening test. Alcoholism: Clinical & Experimental Research 1987; 11: 269-273.
60. Hodgins DC, Guebaly N. More data on the Addiction Severity Index. Reliability and validity with the mentally ill substance abuser. J Nerv Ment Dis 1992; 180: 197-201.
61. Mullis K, Faloona F, Scharf S, Saiki R, Horn G, Erlich H. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harbor Symp Quant Biol 1986; 51: 263-272.
62. Comings DE, Muhleman D, Gade R, Chiu C, Wu H, Dietz G, Winn-Dean E, Ferry L, Rosenthal RJ, Lesieur HR, Rugle L, Sverd J, Johnson P, MacMurray JP. Exon and intron mutations in the human tryptophan 2,3-dioxygenase gene and their potential association with Tourette syndrome, substance abuse and other psychiatric disorders. Pharmacogenetics 1996; 6: 307-318.
63. Comings DE. Search for the Tourette Syndrome and Human Behavior Genes. Hope Press: Duarte, CA, 1996.
64. Comings DE, Comings BG. A controlled study of Tourette syndrome. I. Attention-deficit disorder, learning disorders, and school problems. Am J Hum Genet 1987; 41: 701-741.
65. Tivol EA, Shalish C, Schuback DE, Hus Y-P, Breakefield XO. Mutational analysis of the human MAOA gene. Am J Med Gen (Neuropsych Genet) 1996; 67: 92-97.